Oxford Cancer Analytics Ltd
12437885
Healthy
No risk factors detected.
Details
Compliance
Accounts
Confirmation statement
Industry
Officers
director · Since 03/02/2020
PRESIDENT & COO, OXFORD CANCER ANALYTICS
GERMAN · ENGLAND · Age 29
director · Since 19/11/2024
INVESTMENT PROFESSIONAL
BRITISH · SPAIN · Age 29
director · Since 30/06/2025
VENTURE CAPITAL
BRITISH · UNITED KINGDOM · Age 44
Also on 1 other board
Persons with Significant Control
Former PSCs
Dr Jian Rui Liu
Ceased 27/11/2024
Mr Andreas Joseph Halner
Ceased 27/11/2024
CompanyRankvs 205+ SIC 72110 peers80
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/12/2024
Net Worth
£8.4M
Balance sheet strength
Cash
£8.2M
Cash in the bank
Net Current Assets
£8.2M
Working capital
Current Assets
£8.2M
Current Liabilities
£22k
Fixed Assets
£221k
Debtors
£403
Director Loans
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2024 | 370.51 | +£6.4M |
| 2023 | 118.81 | -£1.1M |
| 2023 | 159.28 | +£2.1M |
| 2022 | 26.06 | — |
| 2021 | 0.98 | — |
Derived from filed accounts. Not audited figures.